StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

CGONBullishAnalyst Target Updateanalyst
Medium materiality6/10

Guggenheim Raises CG Oncology Target to $120

Nov 19, 2026, 10:07 AM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

The sizable target increase supports a bullish view, while the signal reflects a single analyst opinion rather than a confirmed change in fundamentals.

AI summary

What happened, with direct paths to the underlying reporting

Guggenheim raised its CG Oncology price target to $120 from an $80 posted price, indicating substantial analyst-assessed upside.

  • Analyst target: $120; posted price: $80.
  • Price change since signal: +1.52%.

Key facts

  1. 01

    Target: $120

  2. 02

    Posted price: $80

  3. 03

    Analyst firm: Guggenheim

  4. 04

    Analyst: Brad Canino

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.